Klaus Witthohn
Impact in
- Biotechnology top 5%
- Transgenic Plants and Applications
-
- Toxin Mechanisms and Immunotoxins
Papers in
-
- Transgenic Plants and Applications 10
- Immunology 12
- Toxin Mechanisms and Immunotoxins 12
- Co-authors
- Martin Langer (7 shared papers)Hans Lentzen (6 shared papers)W. Blaschek (1 shared paper)Birgit Classen (1 shared paper)Jürgen Eck (2 shared papers)Hartwig Steckel (3 shared papers)Babette Möckel (1 shared paper)Holger Zinke (1 shared paper)
In The Last Decade
Klaus Witthohn
16 papers receiving 395 citations
Peers
Comparison fields: 5 of 71
- Biotechnology 111
- Immunology 192
- Complementary and alternative medicine 39
- Molecular Biology 196
- Pharmaceutical Science 14
Countries citing papers authored by Klaus Witthohn
This map shows the geographic impact of Klaus Witthohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Witthohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Witthohn more than expected).
Fields of papers citing papers by Klaus Witthohn
This network shows the impact of papers produced by Klaus Witthohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Witthohn. The network helps show where Klaus Witthohn may publish in the future.
Co-authors
The 25 scholars most cited alongside Klaus Witthohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 73 | |
| 2 | 2000 | 64 | |
| 3 | 2004 | 56 | |
| 4 | 2011 | 43 | |
| 5 | 2003 | 42 | |
| 6 | 2001 | 35 | |
| 7 | 2004 | 25 | |
| 8 | 2003 | 23 | |
| 9 | 2005 | 13 | |
| 10 | 2003 | 12 | |
| 11 | 2003 | 12 | |
| 12 | 2014 | 7 | |
| 13 | Binding of recombinant mistletoe lectin (aviscumine) to resected human adenocarcinoma of the lung. | 2005 | 5 |
| 14 | 2008 | 4 | |
| 15 | 1996 | 2 | |
| 16 | 1999 | 1 | |
| 17 | 2015 | 1 |
About Klaus Witthohn
Klaus Witthohn is a scholar working on Biotechnology, Immunology, Plant Science, Pharmaceutical Science and Molecular Biology, having authored 17 papers that have together received 418 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (12 papers), Transgenic Plants and Applications (10 papers), Plant Parasitism and Resistance (3 papers), Glycosylation and Glycoproteins Research (2 papers), Protein purification and stability (2 papers), Drug Solubulity and Delivery Systems (2 papers), Inhalation and Respiratory Drug Delivery (1 paper) and Phytochemistry and biological activity of medicinal plants (1 paper). The work is most often cited by research in Biotechnology (111 citations), Immunology (192 citations), Complementary and alternative medicine (39 citations), Molecular Biology (196 citations) and Pharmaceutical Science (14 citations). Klaus Witthohn has collaborated with scholars based in Germany, Austria and Croatia. Frequent co-authors include Martin Langer, Hans Lentzen, W. Blaschek, Birgit Classen, Jürgen Eck, Hartwig Steckel, Babette Möckel, Holger Zinke, Jasna Peter‐Katalinić and Johannes Müthing. Their work appears in journals such as European Journal of Cancer, Biochemical and Biophysical Research Communications, European Journal of Biochemistry, The FASEB Journal and Electrophoresis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.